actually if you go back and check the statement is dated the 18th but he makes reference to the meeting in the future tense giving the strong impression that this communique was actually written before any meeting. GLTA
Tomorrow at 11 AM we all find out whether the FDA agrees with Camargo/Elite that all trialing for ELI200 has been completed for the the FDA to make a decision on the 505B2 NDA approval. Nasrat Hakim is obviously not saying yet on the FDA decision and is adhering to his previous statement that he would release the info at $ELTP's 11AM Nov 19 CC.
IMO NH is acting in a very professional manner and keeping $ELTP exactly in FDA as well as SEC guidelines for such Material Event PR details.
News 
Market Data 
Discover 
